We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+23%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$6.04B
AUM Growth
+$675M
Cap. Flow
-$174M
Cap. Flow %
-2.89%
Top 10 Hldgs %
30.62%
Holding
267
New
23
Increased
78
Reduced
137
Closed
22

Top Buys

Rank Stock Value
1
TRUP icon
Trupanion
TRUP
+$47.8M
2
MQ icon
Marqeta
MQ
+$27.4M
3
CAE icon
CAE Inc
CAE
+$26.6M
4
META icon
Meta Platforms (Facebook)
META
+$24.2M
5
LLY icon
Eli Lilly
LLY
+$23.4M

Top Sells

Rank Stock Value
1
MAXR
Maxar Technologies Inc. Common Stock
MAXR
+$50.7M
2
ENPH icon
Enphase Energy
ENPH
+$40.3M
3
PI icon
Impinj
PI
+$33.7M
4
XMTR icon
Xometry
XMTR
+$28.3M
5
TSLA icon
Tesla
TSLA
+$21.9M

Sector Composition

Rank Sector Weight
1 Technology 33.07%
2 Consumer Discretionary 21.47%
3 Healthcare 16.72%
4 Industrials 9.41%
5 Communication Services 9.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLB icon
176
SLB Ltd
SLB
$80.4B
$1.8M 0.03%
36,719
+55
+0.2% +$2.92K
RVNC
177
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.79M 0.03%
55,517
+2,578
+5% +$80.4K
IAUX
178
i-80 Gold Corp
IAUX
$1.46B
$1.78M 0.03%
+725,772
New +$1.81M
ISEE
179
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$1.75M 0.03%
71,957
-335
-0.5% -$7.33K
PRTS icon
180
CarParts.com
PRTS
$70M
$1.73M 0.03%
32,466
-17
-0.1% -$1.08K
RLAY icon
181
Relay Therapeutics
RLAY
$4.16B
$1.69M 0.03%
102,600
-5,358
-5% -$96.1K
CROX icon
182
Crocs
CROX
$5.34B
$1.69M 0.03%
13,348
+307
+2% +$37.1K
CURV icon
183
Torrid Holdings
CURV
$216M
$1.66M 0.03%
380,729
+336,088
+753% +$1.06M
ATVI
184
DELISTED
Activision Blizzard
ATVI
$1.64M 0.03%
19,169
+176
+0.9% +$13.7K
UTHR icon
185
United Therapeutics
UTHR
$21.5B
$1.6M 0.03%
7,140
+2,689
+60% +$663K
BRK.B icon
186
Berkshire Hathaway Class B
BRK.B
$1.11T
$1.38M 0.02%
4,459
+132
+3% +$40.7K
SHW icon
187
Sherwin-Williams
SHW
$78.5B
$1.34M 0.02%
5,970
+175
+3% +$40K
KRTX
188
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$1.33M 0.02%
7,340
-231
-3% -$44.2K
CYBR
189
DELISTED
CyberArk
CYBR
$1.3M 0.02%
8,794
STKS icon
190
The ONE Group
STKS
$50.4M
$1.25M 0.02%
+153,715
New +$1.21M
PEN icon
191
Penumbra
PEN
$12.5B
$1.23M 0.02%
4,408
+21
+0.5% +$5.36K
VEEV icon
192
Veeva Systems
VEEV
$43.2B
$1.22M 0.02%
6,653
CMG icon
193
Chipotle Mexican Grill
CMG
$44.1B
$1.2M 0.02%
35,050
+2,400
+7% +$75.4K
ETNB
194
DELISTED
89bio
ETNB
$1.16M 0.02%
76,003
+26,126
+52% +$341K
SONO icon
195
Sonos
SONO
$1.85B
$1.11M 0.02%
56,480
+547
+1% +$10.4K
ARLO icon
196
Arlo Technologies
ARLO
$1.45B
$1.08M 0.02%
177,477
-19,312
-10% -$85.6K
AXNX
197
DELISTED
Axonics, Inc. Common Stock
AXNX
$1.05M 0.02%
+19,256
New +$1.12M
CYTK icon
198
Cytokinetics
CYTK
$9.64B
$944K 0.02%
26,837
-483
-2% -$19.7K
FSLY icon
199
Fastly Inc
FSLY
$3.87B
$889K 0.01%
50,076
-617
-1% -$7.84K
TXG icon
200
10x Genomics
TXG
$9.69B
$876K 0.01%
15,710
+5,588
+55% +$261K

Similar funds

Gilder Gagnon Howe & Co's Q1 2023 Portfolio in Review

As of Q1 2023, Gilder Gagnon Howe & Co held 267 positions worth $6.04B, up 13% from $5.36B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Gilder Gagnon Howe & Co's Q1 2023 filing shows 23 new, 78 increased, 137 reduced and 22 closed positions. Its largest new stake was Marqeta: 1,226,454 shares worth $22.4M. The largest sale was Maxar Technologies Inc. Common Stock, an estimated $50.7M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Gilder Gagnon Howe & Co's largest Q1 2023 buy was Marqeta: 1,226,454 shares worth $22.4M.
  • Gilder Gagnon Howe & Co added most to Trupanion in Q1 2023, an estimated $47.8M increase.
  • Gilder Gagnon Howe & Co's biggest Q1 2023 reduction was Enphase Energy, cutting an estimated $40.3M.
  • Gilder Gagnon Howe & Co fully exited Maxar Technologies Inc. Common Stock in Q1 2023, selling an estimated $50.7M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 31% of its $6.04B portfolio in Q1 2023.
  • Gilder Gagnon Howe & Co opened 23 new positions and closed 22 in Q1 2023.
  • Gilder Gagnon Howe & Co's portfolio value rose 13% quarter-over-quarter to $6.04B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2023, filed 15 May 2023.